Close-out visits are scheduled to be performed by GCT team in Russia for a Phase III multi-center double-blind anaesthesiology study sponsored by a leading Russian pharmaceutical company.
120 patients were enrolled and received study treatment within aggressive timelines. The completion of the enrollment is an important milestone for the clinical program aimed at bringing an anaesthetic to the market.
GCT is contracted to provide overall project management, LEC submissions, site contracting, clinical monitoring, safety reporting, data management, biostatistics and final report preparation.